Publication | Open Access

Immunotherapy with the use of tumor-infiltrating lymphocytes and interleukin-2 as adjuvant treatment in stage III non-small-cell lung cancer: A pilot study

Tumor-infiltrating LymphocytesTumor ImmunologyCancer ImmunosurveillanceMedicineImmunologyAdjuvant TreatmentImmune Checkpoint InhibitorBronchial NeoplasmCancer TreatmentImmunotherapyOncologyRadiation OncologyTumor MicroenvironmentLung CancerPilot Study